IL-38 polymorphisms are associated with increased susceptibility for autoimmune diseases such as psoriasis, spondyloarthritis, rheumatoid arthritis (RA), psoriatic arthritis, and systemic-lupus-erythematosus (SLE) [17,18,19,20]. Here, IL1F10 is linked to rheumatoid arthritis.